Looking for obesity-drug stocks to buy? Check out the biggest and best: Eisai, Novo Nordisk, and Roche.
News & Analysis: Eisai Co., Ltd (ADR)
The biopharma's shares soared by double-digits Wednesday on a strong Q4 earnings release.
Experts think they know how to treat Alzheimer's disease, but it won't be easy. Here's how cannabis could help.
See how soon-to-be-released BACE inhibitor safety data could play a huge role in the future of Alzheimer's drug development.
Prices for cancer medications are soaring.
Arena and VIVUS have had a tough year. Is it finally time to take the contrarian view and consider them worthy investments?
Biogen, Eisai join up in Alzheimer’s drug pact.
Xoma, Biogen, Agenus, and GSK could all loom large in health care headlines this morning.
These are the 10 countries with the longest life expectancy. See what factors have allowed their citizens to live longer as well as how you might be able to benefit from their longevity.
An Eisai purchase of Arena Pharmaceuticals makes sense from all angles.